Protein targets of inflammatory serine proteases and cardiovascular disease
暂无分享,去创建一个
Ram Sharony | A. Galloway | P. Mignatti | G. Pintucci | Pey-Jen Yu | Joy Park | Aubrey C Galloway | Paolo Mignatti | Giuseppe Pintucci | Pey‐Jen Yu | R. Sharony | Joy Park
[1] L. Iacoviello,et al. Cathepsin G--induced release of PAI-1 in the culture medium of endothelial cells: a new thrombogenic role for polymorphonuclear leukocytes? , 1993, The Journal of laboratory and clinical medicine.
[2] Stefan Offermanns,et al. Mammalian G proteins and their cell type specific functions. , 2005, Physiological reviews.
[3] T. Chao,et al. The endogenous immune response modulates the course of IgA-immune complex mediated nephropathy. , 2006, Kidney international.
[4] B. Clarke,et al. Neutrophil activation detected by increased neutrophil elastase activity in type 1 (insulin-dependent) diabetes mellitus. , 1989, Diabetes research.
[5] S. Schwartz,et al. Osteopontin is synthesized by macrophage, smooth muscle, and endothelial cells in primary and restenotic human coronary atherosclerotic plaques. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[6] H. Neurath,et al. Mast cell proteases. , 1981, Methods in enzymology.
[7] Xiaomin Wang,et al. Leukocyte elastase induces epithelial apoptosis: role of mitochondial permeability changes and Akt. , 2004, American journal of physiology. Gastrointestinal and liver physiology.
[8] E. Diamandis,et al. Functional Roles of Human Kallikrein-related Peptidases* , 2009, The Journal of Biological Chemistry.
[9] R. Weiss,et al. The mitogenic effect of thrombin in vascular smooth muscle cells is largely due to basic fibroblast growth factor. , 1993, The Journal of biological chemistry.
[10] Paula Clancy,et al. Association Between Osteopontin and Human Abdominal Aortic Aneurysm , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[11] C. Orosz,et al. Regulation of endothelial VCAM-1 expression in murine cardiac grafts. Roles for TNF and IL4. , 1995, The American journal of pathology.
[12] P. Libby,et al. CC Chemokine Receptor-1 Activates Intimal Smooth Muscle-Like Cells in Graft Arterial Disease , 2009, Circulation.
[13] G. Hayman,et al. Thrombin modulates vectorial secretion of extracellular matrix proteins in cultured endothelial cells. , 1997, The American journal of physiology.
[14] Thomas A Luger,et al. Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response. , 2005, Endocrine reviews.
[15] S. Verma,et al. Endothelin Antagonism and Interleukin-6 Inhibition Attenuate the Proatherogenic Effects of C-Reactive Protein , 2002, Circulation.
[16] N. Fukazawa,et al. Cathepsin g is required for sustained inflammation and tissue injury after reperfusion of ischemic kidneys. , 2007, The American journal of pathology.
[17] Nagadhara Dronadula,et al. Thrombin induces expression of FGF-2 via activation of PI3K-Akt-Fra-1 signaling axis leading to DNA synthesis and motility in vascular smooth muscle cells. , 2006, American journal of physiology. Cell physiology.
[18] J. Fallon,et al. Tissue Factor in the Pathogenesis of Atherosclerosis , 1997, Thrombosis and Haemostasis.
[19] P. Densen,et al. Mechanisms of contraction induced by human leukocytes in normal and atherosclerotic arteries. , 1991, Circulation research.
[20] Activation of pro-(matrix metalloproteinase-2) (pro-MMP-2) by thrombin is membrane-type-MMP-dependent in human umbilical vein endothelial cells and generates a distinct 63 kDa active species. , 2001, The Biochemical journal.
[21] A. Ariel,et al. IL-2 induces T cell adherence to extracellular matrix: inhibition of adherence and migration by IL-2 peptides generated by leukocyte elastase. , 1998, Journal of immunology.
[22] M. Hollenberg,et al. Detection of functional receptors for the proteinase-activated-receptor-2-activating polypeptide, SLIGRL-NH2, in rat vascular and gastric smooth muscle. , 1995, Canadian journal of physiology and pharmacology.
[23] D. Granger,et al. Modulation of the Inflammatory Response in Cardiovascular Disease , 2004, Hypertension.
[24] Jingwu Z. Zhang,et al. Role of osteopontin in induction of monocyte chemoattractant protein 1 and macrophage inflammatory protein 1beta through the NF-kappaB and MAPK pathways in rheumatoid arthritis. , 2009, Arthritis and rheumatism.
[25] L. Schack,et al. Osteopontin Is Cleaved at Multiple Sites Close to Its Integrin-binding Motifs in Milk and Is a Novel Substrate for Plasmin and Cathepsin D* , 2010, The Journal of Biological Chemistry.
[26] C. Derian,et al. Blocking the Protease-Activated Receptor 1-4 Heterodimer in Platelet-Mediated Thrombosis , 2006, Circulation.
[27] R. Anderson,et al. Neutrophil lysosomal degradation of human CRP: CRP-derived peptides modulate neutrophil function. , 1988, Clinical and experimental immunology.
[28] C. Feistritzer,et al. Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation. , 2005, Blood.
[29] TatsuhikoSudo,et al. Involvement of Apoptosis Signal-Regulating Kinase-1 on Angiotensin II-Induced Monocyte Chemoattractant Protein-1 Expression , 2004 .
[30] Wuyuan Lu,et al. Multiple pathways of amino terminal processing produce two truncated variants of RANTES/CCL5 , 2005, Journal of leukocyte biology.
[31] E. Antunes,et al. The plasma and tissue kininogen-kallikrein-kinin system: role in the cardiovascular system. , 2005, Current medicinal chemistry. Cardiovascular and hematological agents.
[32] M. Simon,et al. Defective platelet activation in G alpha(q)-deficient mice. , 1997, Nature.
[33] L. Dell’Italia,et al. Dissecting the role of chymase in angiotensin II formation and heart and blood vessel diseases. , 2002, Current opinion in cardiology.
[34] R. Crystal,et al. Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in a human bronchial epithelial cell line. , 1992, The Journal of clinical investigation.
[35] R. Guldberg,et al. Inactivation of the Osteopontin Gene Enhances Vascular Calcification of Matrix Gla Protein–deficient Mice , 2002, The Journal of experimental medicine.
[36] G. Downey,et al. Neutrophil-mediated epithelial injury during transmigration: role of elastase. , 2001, American journal of physiology. Gastrointestinal and liver physiology.
[37] A. Loewy,et al. An Osteopontin–NADPH Oxidase Signaling Cascade Promotes Pro–Matrix Metalloproteinase 9 Activation in Aortic Mesenchymal Cells , 2006, Circulation research.
[38] D. Ku,et al. Receptor Mechanism of Thrombin‐Induced Endothelium‐Dependent and Endothelium‐Independent Coronary Vascular Effects in Dogs , 1993, Journal of cardiovascular pharmacology.
[39] J. Griffin,et al. Activated protein C variants with normal cytoprotective but reduced anticoagulant activity. , 2004, Blood.
[40] D. Remick,et al. Neutralization of Groα and macrophage inflammatory protein-2 attenuates renal ischemia/reperfusion injury , 2001 .
[41] M. Stack,et al. Human mast cell tryptase activates single-chain urinary-type plasminogen activator (pro-urokinase). , 1994, The Journal of biological chemistry.
[42] J. Heemskerk,et al. Synergistic Effect of Thrombin on Collagen-Induced Platelet Procoagulant Activity Is Mediated Through Protease-Activated Receptor-1 , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[43] A. Galloway,et al. Mechanisms of c-reactive protein up-regulation in arterialized vein grafts. , 2006, Surgery.
[44] S. Coughlin,et al. Protease‐activated receptors in hemostasis, thrombosis and vascular biology , 2005, Journal of thrombosis and haemostasis : JTH.
[45] J. Fischer,et al. Cholesterol Enhances Thrombin-Induced Release of Fibroblast Growth Factor-2 in Human Vascular Smooth Muscle Cells , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[46] H. Kantarjian,et al. Biology of platelet-derived growth factor and its involvement in disease. , 2006, Mayo Clinic proceedings.
[47] D. Carden,et al. Neutrophil elastase promotes lung microvascular injury and proteolysis of endothelial cadherins. , 1998, American journal of physiology. Heart and circulatory physiology.
[48] L. Schwartz,et al. The fibrinogenolytic activity of purified tryptase from human lung mast cells. , 1985, Journal of immunology.
[49] K. Mann,et al. What is all that thrombin for? , 2003, Journal of thrombosis and haemostasis : JTH.
[50] J. Wallace,et al. Protease-activated receptors in inflammation, neuronal signaling and pain. , 2001, Trends in pharmacological sciences.
[51] A. Sommer,et al. Human basic fibroblast growth factor gene encodes four polypeptides: three initiate translation from non-AUG codons. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[52] M. Hollenberg,et al. Proteinases, proteinase-activated receptors (PARs) and the pathophysiology of cancer and diseases of the cardiovascular, musculoskeletal, nervous and gastrointestinal systems , 2008, Naunyn-Schmiedeberg's Archives of Pharmacology.
[53] A. Prats,et al. Alternative translation of human fibroblast growth factor 2 mRNA occurs by internal entry of ribosomes , 1995, Molecular and cellular biology.
[54] A. Schmaier,et al. High molecular weight kininogen binds to platelets by its heavy and light chains and when bound has altered susceptibility to kallikrein cleavage. , 1992, Blood.
[55] A. Agarwal,et al. PAR1 Is a Matrix Metalloprotease-1 Receptor that Promotes Invasion and Tumorigenesis of Breast Cancer Cells , 2005, Cell.
[56] A. Newby,et al. Molecular mechanisms in intimal hyperplasia , 2000, The Journal of pathology.
[57] D. Katsaros,et al. Human kallikrein 14: a new potential biomarker for ovarian and breast cancer. , 2003, Cancer research.
[58] S. Devaraj,et al. C-Reactive Protein Decreases Prostacyclin Release From Human Aortic Endothelial Cells , 2003, Circulation.
[59] J. Taipale,et al. Human Mast Cell Chymase and Leukocyte Elastase Release Latent Transforming Growth Factor-β1 from the Extracellular Matrix of Cultured Human Epithelial and Endothelial Cells (*) , 1995, The Journal of Biological Chemistry.
[60] Q. Zen,et al. Effect of human C-reactive protein on chemokine and chemotactic factor-induced neutrophil chemotaxis and signaling. , 1998, Journal of immunology.
[61] E. Diamandis,et al. Proteinase-activated Receptors, Targets for Kallikrein Signaling* , 2006, Journal of Biological Chemistry.
[62] A. Galloway,et al. Matrix metalloproteinase expression in vein grafts: role of inflammatory mediators and extracellular signal-regulated kinases-1 and -2. , 2006, American journal of physiology. Heart and circulatory physiology.
[63] M. Okazaki,et al. Osteopontin-derived peptide SVVYGLR induces angiogenesis in vivo. , 2004, Dental materials journal.
[64] M. Hollenberg,et al. International Union of Pharmacology. XXVIII. Proteinase-Activated Receptors , 2002, Pharmacological Reviews.
[65] S. Akira,et al. Caspase-1-independent, Fas/Fas ligand-mediated IL-18 secretion from macrophages causes acute liver injury in mice. , 1999, Immunity.
[66] A. Kuliopulos,et al. Activation and inhibition of G protein-coupled receptors by cell-penetrating membrane-tethered peptides , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[67] T. Kôno,et al. Insulin-like effects of trypsin on fat cells. Localization of the metabolic steps and the cellular site affected by the enzyme. , 1971, The Journal of biological chemistry.
[68] C. Turck,et al. Specificity of the thrombin receptor for agonist peptide is defined by its extracellular surface , 1994, Nature.
[69] S. Schwartz,et al. Neutralizing antibodies directed against osteopontin inhibit rat carotid neointimal thickening after endothelial denudation. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[70] Thiennu H. Vu,et al. Thrombin receptor expression in normal and atherosclerotic human arteries. , 1992, The Journal of clinical investigation.
[71] M. Runge,et al. The Role of Secondary Growth Factor Production in Thrombin-lnduced Proliferation of Vascular Smooth Muscle Cells , 1998, Seminars in thrombosis and hemostasis.
[72] M. Benezra,et al. Thrombin-induced release of active basic fibroblast growth factor-heparan sulfate complexes from subendothelial extracellular matrix. , 1993, Blood.
[73] C. Boudier,et al. The elastolytic activity of cathepsin G: an ex vivo study with dermal elastin. , 1991, American journal of respiratory cell and molecular biology.
[74] J. Trejo,et al. Caveolae are required for protease-selective signaling by protease-activated receptor–1 , 2009, Proceedings of the National Academy of Sciences.
[75] M. Hollenberg,et al. Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more , 2008, British journal of pharmacology.
[76] James T. Willerson,et al. Modulation of C-Reactive Protein–Mediated Monocyte Chemoattractant Protein-1 Induction in Human Endothelial Cells by Anti-Atherosclerosis Drugs , 2001 .
[77] M. Denis,et al. Release of interleukin-8, interleukin-6, and colony-stimulating factors by upper airway epithelial cells: implications for cystic fibrosis. , 1993, American journal of respiratory cell and molecular biology.
[78] N. Yamamoto,et al. Essential role of the cryptic epitope SLAYGLR within osteopontin in a murine model of rheumatoid arthritis. , 2003, The Journal of clinical investigation.
[79] S. Marcus,et al. Activation of progelatinase A (MMP‐2) by neutrophil elastase, cathepsin G, and proteinase‐3: A role for inflammatory cells in tumor invasion and angiogenesis , 2001, Journal of cellular physiology.
[80] B. Payrastre,et al. A key role of adenosine diphosphate in the irreversible platelet aggregation induced by the PAR1-activating peptide through the late activation of phosphoinositide 3-kinase. , 1999, Blood.
[81] M. D'Andrea,et al. Characterization of Thrombin-Induced Leukocyte Rolling and Adherence: A Potential Proinflammatory Role for Proteinase-Activated Receptor-41 , 2002, The Journal of Immunology.
[82] A. Galloway,et al. Thrombin cleaves the high molecular weight forms of basic fibroblast growth factor (FGF-2): a novel mechanism for the control of FGF-2 and thrombin activity , 2008, Oncogene.
[83] D. Sheppard,et al. Osteopontin N-terminal Domain Contains a Cryptic Adhesive Sequence Recognized by α9β1 Integrin* , 1996, The Journal of Biological Chemistry.
[84] H. Kanaide,et al. Role of protease-activated receptors in the vascular system. , 2003, Journal of atherosclerosis and thrombosis.
[85] E. Van Obberghen-Schilling,et al. Distinct signals via Rho GTPases and Src drive shape changes by thrombin and sphingosine-1-phosphate in endothelial cells. , 2002, Journal of cell science.
[86] S. Weiss. Tissue destruction by neutrophils. , 1989, The New England journal of medicine.
[87] Y. Matsui,et al. Osteopontin Deficiency Attenuates Atherosclerosis in Female Apolipoprotein E–Deficient Mice , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[88] S. Akira,et al. Defective NK cell activity and Th1 response in IL-18-deficient mice. , 1998, Immunity.
[89] A. A. Taylor,et al. Inflammation in the course of early myocardial ischemia , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[90] K. Fujikawa,et al. The activation of pro-urokinase by plasma kallikrein and its inactivation by thrombin. , 1986, The Journal of biological chemistry.
[91] H. Pass,et al. Correlation between plasma osteopontin levels and aortic valve calcification: potential insights into the pathogenesis of aortic valve calcification and stenosis. , 2009, The Journal of thoracic and cardiovascular surgery.
[92] L. Joosten,et al. An IFN-γ-Independent Proinflammatory Role of IL-18 in Murine Streptococcal Cell Wall Arthritis , 2000, The Journal of Immunology.
[93] R. Stockley,et al. Lung lavage fluid from patients with alpha 1-proteinase inhibitor deficiency or chronic obstructive bronchitis: anti-elastase function and cell profile. , 1987, Clinical science.
[94] Z. Fayad,et al. Associations between plasma osteopontin levels and the severities of coronary and aortic atherosclerosis. , 2010, Atherosclerosis.
[95] K. Aoshiba,et al. C-reactive protein products generated by neutrophil elastase promote neutrophil apoptosis. , 2006, Archives of medical research.
[96] Carlos López-Otín,et al. A genomic analysis of rat proteases and protease inhibitors. , 2004, Genome research.
[97] R. Busuttil,et al. The inhibition of neutrophil elastase ameliorates mouse liver damage due to ischemia and reperfusion , 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[98] G. D. Hunter,et al. Proteinase-activated receptors. , 2001, Pharmacological reviews.
[99] C. Alpers,et al. Osteopontin expression in angiotensin II-induced tubulointerstitial nephritis. , 1994, Kidney international.
[100] O. Kwon,et al. Pro-tumour necrosis factor cleavage enzyme in macrophage membrane/particulate. , 1993, Immunology.
[101] J. Verhoef,et al. Inactivation of recombinant human tumor necrosis factor-alpha by proteolytic enzymes released from stimulated human neutrophils. , 1991, Journal of immunology.
[102] S. Yoshitake,et al. Antibody to thrombin receptor inhibits neointimal smooth muscle cell accumulation without causing inhibition of platelet aggregation or altering hemostatic parameters after angioplasty in rat. , 1998, Circulation research.
[103] J. Abraham,et al. Heparin blockade of thrombin-induced smooth muscle cell migration involves inhibition of epidermal growth factor (EGF) receptor transactivation by heparin-binding EGF-like growth factor. , 2000, Circulation research.
[104] P. Mak,et al. Effects of elastase and cathepsin G on the levels of membrane and soluble TNFα , 2005, Biological chemistry.
[105] Richard T. Lee,et al. Macrophages and atherosclerotic plaque stability , 1996, Current opinion in lipidology.
[106] P. Cuatrecasas. Properties of the insulin receptor of isolated fat cell membranes. , 1971, The Journal of biological chemistry.
[107] C. Ince,et al. Recombinant activated protein C treatment improves tissue perfusion and oxygenation in septic patients measured by near-infrared spectroscopy , 2009, Critical care.
[108] H. Davis,et al. Regulation of endothelial cell gap formation and barrier dysfunction: Role of myosin light chain phosphorylation , 1995, Journal of cellular physiology.
[109] A. Galloway,et al. Lack of ERK activation and cell migration in FGF‐2‐deficient endothelial cells , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[110] M. Schork,et al. Reduction of the Extent of Ischemic Myocardial Injury by Neutrophil Depletion in the Dog , 1983, Circulation.
[111] E. Edelman,et al. Increased Thrombosis After Arterial Injury in Human C-Reactive Protein–Transgenic Mice , 2003, Circulation.
[112] A. Leger,et al. Protease-Activated Receptors in Cardiovascular Diseases , 2006, Circulation.
[113] L. Matrisian,et al. Osteopontin, a Novel Substrate for Matrix Metalloproteinase-3 (Stromelysin-1) and Matrix Metalloproteinase-7 (Matrilysin)* , 2001, The Journal of Biological Chemistry.
[114] C. Owen,et al. The cell biology of leukocyte‐mediated proteolysis , 1999, Journal of leukocyte biology.
[115] Wuyuan Lu,et al. N‐terminal proteolytic processing by cathepsin G converts RANTES/CCL5 and related analogs into a truncated 4‐68 variant , 2006, Journal of leukocyte biology.
[116] S. Coughlin,et al. Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor. , 1993, The Journal of clinical investigation.
[117] S. Roman-Roman,et al. In Vitro Processing of Human Tumor Necrosis Factor-α (*) , 1995, The Journal of Biological Chemistry.
[118] A. Galloway,et al. Basic fibroblast growth factor (FGF‐2): The high molecular weight forms come of age , 2007, Journal of cellular biochemistry.
[119] J. Aschner,et al. Thrombin receptor activating peptides induce Ca2+ mobilization, barrier dysfunction, prostaglandin synthesis, and platelet‐derived growth factor mRNA expression in cultured endothelium , 1993, Journal of cellular physiology.
[120] E. Diamandis,et al. The emerging roles of human tissue kallikreins in cancer , 2004, Nature Reviews Cancer.
[121] B. Rauch,et al. Thrombin- and Factor Xa–Induced DNA Synthesis Is Mediated by Transactivation of Fibroblast Growth Factor Receptor-1 in Human Vascular Smooth Muscle Cells , 2004, Circulation research.
[122] D. Sheppard,et al. The Integrin α9β1 Binds to a Novel Recognition Sequence (SVVYGLR) in the Thrombin-cleaved Amino-terminal Fragment of Osteopontin* , 1999, The Journal of Biological Chemistry.
[123] C. Kahn,et al. Tryptic activation of the insulin receptor. Proteolytic truncation of the alpha-subunit releases the beta-subunit from inhibitory control. , 1988, The Journal of biological chemistry.
[124] C. Murry,et al. Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. , 1998, The American journal of pathology.
[125] E. Diamandis,et al. Human tissue kallikreins: physiologic roles and applications in cancer. , 2004, Molecular cancer research : MCR.
[126] W. Aird,et al. Thrombin and Phenotypic Modulation of the Endothelium , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[127] P. Libby,et al. Neutrophil Elastase in Human Atherosclerotic Plaques: Production by Macrophages , 2003, Circulation.
[128] E. Diamandis,et al. Kallikrein-related peptidases: proteolysis and signaling in cancer, the new frontier , 2010, Biological chemistry.
[129] Sridevi Devaraj,et al. Demonstration That C-Reactive Protein Decreases eNOS Expression and Bioactivity in Human Aortic Endothelial Cells , 2002, Circulation.
[130] A. Wiedlocha,et al. Functional diversity of FGF-2 isoforms by intracellular sorting. , 2006, BioEssays : news and reviews in molecular, cellular and developmental biology.
[131] N. Itoh,et al. Evolution of the Fgf and Fgfr gene families. , 2004, Trends in genetics : TIG.
[132] Darrell R. Abernethy,et al. International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels , 2003, Pharmacological Reviews.
[133] D. Ku,et al. Expression of thrombin receptors in human atherosclerotic coronary arteries leads to an exaggerated vasoconstrictory response in vitro. , 1997, Journal of cardiovascular pharmacology.
[134] D. Kunz,et al. Selective proteolytic cleavage of IL-2 receptor and IL-6 receptor ligand binding chains by neutrophil-derived serine proteases at foci of inflammation. , 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[135] V. Wheaton,et al. Tethered ligand agonist peptides. Structural requirements for thrombin receptor activation reveal mechanism of proteolytic unmasking of agonist function. , 1992, The Journal of biological chemistry.
[136] Harry,et al. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. , 1993, Blood.
[137] L. Liaw,et al. Osteopontin: A Multifunctional Molecule Regulating Chronic Inflammation and Vascular Disease , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[138] C. Geczy,et al. C-reactive Protein : Relationship with Age, Sex, and Hormone Replacement Treatment and Lipopolysaccharide Potentiate Monocyte Tissue Factor Induction by Γ Interferon- Interferon-␥ and Lipopolysaccharide Potentiate Monocyte Tissue Factor Induction by C-reactive Protein Relationship with Age, Sex, and , 2022 .
[139] R. Bizios,et al. Thrombin‐Induced Alterations in Endothelial Permeability a , 1986, Annals of the New York Academy of Sciences.
[140] W. Ruf,et al. Science review: Role of coagulation protease cascades in sepsis , 2002, Critical care.
[141] M. Schaefer,et al. Requirement of an Intermediate Gene Expression for Biphasic ERK1/2 Activation in Thrombin-stimulated Vascular Smooth Muscle Cells* , 2008, Journal of Biological Chemistry.
[142] Hyuk-Jae Chang,et al. Development of a point-of-care assay system for high-sensitivity C-reactive protein in whole blood. , 2003, Clinica chimica acta; international journal of clinical chemistry.
[143] D. Agrawal,et al. Cellular, molecular and immunological mechanisms in the pathophysiology of vein graft intimal hyperplasia , 2006, Immunology and cell biology.
[144] K. Kinnally,et al. Neutrophil Cathepsin G Promotes Detachment-induced Cardiomyocyte Apoptosis via a Protease-activated Receptor-independent Mechanism* , 2003, Journal of Biological Chemistry.
[145] N. Tsopanoglou,et al. On the Mechanism of Thrombin-induced Angiogenesis , 1999, The Journal of Biological Chemistry.
[146] M. Hollenberg,et al. Proteinase‐activated receptor‐4: evaluation of tethered ligand‐derived peptides as probes for receptor function and as inflammatory agonists in vivo , 2004, British journal of pharmacology.
[147] A. Burlingame,et al. HDL antielastase activity prevents smooth muscle cell anoikis, a potential new antiatherogenic property , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[148] L. Williams,et al. Thrombin stimulates c-sis gene expression in microvascular endothelial cells. , 1986, The Journal of biological chemistry.
[149] Reuven Reich,et al. Thrombin receptor overexpression in malignant and physiological invasion processes , 1998, Nature Medicine.
[150] C. Valeri,et al. Postischemic renal injury is mediated by neutrophils and leukotrienes. , 1989, The American journal of physiology.
[151] D. Remick,et al. Neutralization of Gro alpha and macrophage inflammatory protein-2 attenuates renal ischemia/reperfusion injury. , 2001, The American journal of pathology.
[152] Steven Patierno,et al. Tissue factor, thrombin, and cancer. , 2003, Chest.
[153] J. Baguet,et al. Cathepsin G is associated with atheroma formation in human carotid artery , 2004, Journal of hypertension.
[154] J. Schlessinger,et al. Cell Signaling by Receptor Tyrosine Kinases , 2000, Cell.
[155] Shokei Kim,et al. Involvement of Apoptosis Signal-Regulating Kinase-1 on Angiotensin II-Induced Monocyte Chemoattractant Protein-1 Expression , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[156] P. Scuderi. Suppression of human leukocyte tumor necrosis factor secretion by the serine protease inhibitor p-toluenesulfonyl-L-arginine methyl ester (TAME). , 1989, Journal of immunology.
[157] G. Lozanski,et al. Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein. , 1992, Cytokine.
[158] R. Marthan,et al. Tryptase and agonists of PAR-2 induce the proliferation of human airway smooth muscle cells. , 2001, Journal of applied physiology.
[159] Gunnar Pejler,et al. Mast cell proteases: multifaceted regulators of inflammatory disease. , 2010, Blood.
[160] E. Bramucci,et al. Tissue-factor antigen and activity in human coronary atherosclerotic plaques , 1997, The Lancet.
[161] B. Rauch,et al. Platelet-Derived Growth Factor-BB–Induced Human Smooth Muscle Cell Proliferation Depends on Basic FGF Release and FGFR-1 Activation , 2005, Circulation research.
[162] A. Galloway,et al. Mechanical endothelial damage results in basic fibroblast growth factor-mediated activation of extracellular signal-regulated kinases. , 1999, Surgery.
[163] C. Lucchinetti,et al. Activity of a newly identified serine protease in CNS demyelination. , 2002, Brain : a journal of neurology.
[164] A. Cucina,et al. Autocrine production of basic fibroblast growth factor translated from novel synthesized mRNA mediates thrombin‐induced mitogenesis in smooth muscle cells , 2002, Cell biochemistry and function.
[165] R. Falk,et al. Novel effects of neutrophil-derived proteinase 3 and elastase on the vascular endothelium involve in vivo cleavage of NF-kappaB and proapoptotic changes in JNK, ERK, and p38 MAPK signaling pathways. , 2002, Journal of the American Society of Nephrology : JASN.
[166] D. Spandidos,et al. Genetic diversity of RANTES gene promoter and susceptibility to coronary artery disease and restenosis after percutaneous coronary intervention. , 2009, Thrombosis research.
[167] K. Valerie,et al. Novel Mode for Neutrophil Protease Cathepsin G-Mediated Signaling: Membrane Shedding of Epidermal Growth Factor Is Required for Cardiomyocyte Anoikis , 2008, Circulation research.
[168] P. Ridker,et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. , 2000, The New England journal of medicine.
[169] J. Chen,et al. Osteopontin N-terminal domain contains a cryptic adhesive sequence recognized by alpha9beta1 integrin. , 1996, The Journal of biological chemistry.
[170] M. Gnecchi,et al. Genetic therapies for cardiovascular diseases. , 2005, Trends in molecular medicine.
[171] C. Nathan,et al. Human neutrophil elastase releases a ligand-binding fragment from the 75-kDa tumor necrosis factor (TNF) receptor. Comparison with the proteolytic activity responsible for shedding of TNF receptors from stimulated neutrophils. , 1991, The Journal of biological chemistry.
[172] R. Kettritz,et al. Apoptosis of endothelial cells induced by the neutrophil serine proteases proteinase 3 and elastase. , 1996, The American journal of pathology.
[173] N. Ozer,et al. Plasma soluble osteopontin concentrations are increased in patients with rheumatic mitral stenosis and associated with the severity of mitral valve calcium. , 2006, The American journal of cardiology.
[174] K. Nadeau,et al. The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand. , 1997, The Journal of clinical investigation.
[175] S. Devaraj,et al. C-Reactive Protein Increases Plasminogen Activator Inhibitor-1 Expression and Activity in Human Aortic Endothelial Cells: Implications for the Metabolic Syndrome and Atherothrombosis , 2003, Circulation.
[176] M. Lark,et al. Comparison of the proteoglycanolytic activities of human leukocyte elastase and human cathepsin G in vitro and in vivo. , 1993, Connective tissue research.
[177] Reiko Ohmori,et al. High plasma levels of osteopontin in patients with restenosis after percutaneous coronary intervention. , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[178] N. Tsopanoglou,et al. Role of thrombin in angiogenesis and tumor progression. , 2004, Seminars in thrombosis and hemostasis.
[179] V. Wheaton,et al. Domains specifying thrombin–receptor interaction , 1991, Nature.
[180] M. Mäyränpää,et al. Possible role for mast cell-derived cathepsin G in the adverse remodelling of stenotic aortic valves. , 2006, European heart journal.
[181] G. D. De Meyer,et al. Role of polymorphonuclear leukocytes in collar-induced intimal thickening in the rabbit carotid artery. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[182] C. López-Otín,et al. A genomic view of the complexity of mammalian proteolytic systems. , 2005, Biochemical Society transactions.
[183] T. Suganami,et al. A Paracrine Loop Between Adipocytes and Macrophages Aggravates Inflammatory Changes: Role of Free Fatty Acids and Tumor Necrosis Factor α , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[184] A. Kozubík,et al. Molecular pathology of the fibroblast growth factor family , 2009, Human mutation.
[185] M. Peppelenbosch,et al. Factor Xa: at the crossroads between coagulation and signaling in physiology and disease. , 2008, Trends in molecular medicine.
[186] R. Abboud,et al. Effect of smoking on plasma neutrophil elastase levels. , 1986, The Journal of laboratory and clinical medicine.
[187] E. Milbrandt,et al. Evidence-based Medicine Journal Club Ebm Journal Club Section Editor: a Disheartening Story: Aprotinin in Cardiac Surgery , 2022 .
[188] Moses Rodriguez,et al. Targeting kallikrein 6‐proteolysis attenuates CNS inflammatory disease , 2004, The FASEB Journal.
[189] J. Schlessinger. Cell Signaling by Receptor Tyrosine Kinases , 2000, Cell.
[190] C. Orosz,et al. Regulation of endothelial VCAM-1 expression in murine cardiac grafts. Expression of allograft endothelial VCAM-1 can be manipulated with antagonist of IFN-alpha or IL-4 and is not required for allograft rejection. , 1995, The American journal of pathology.
[191] Reiko Ohmori,et al. Plasma osteopontin levels are associated with the presence and extent of coronary artery disease. , 2003, Atherosclerosis.
[192] M. LeMasurier,et al. Substrate-Assisted Catalysis of the PAR1 Thrombin Receptor , 2000, The Journal of Biological Chemistry.